A first-in-human phase 1 study of simnotrelvir, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjects
- Resource Type
- Article
- Authors
- Yang, Xin-Mei; Yang, Yang; Yao, Bu-Fan; Ye, Pan-Pan; Xu, Yan; Peng, Shao-Ping; Yang, Yu-Mei; Shu, Pan; Li, Pei-Jin; Li, Shan; Hu, Hong-Lin; Li, Qian; Song, Lin-Lin; Chen, Ke-Guang; Zhou, Hai-Yan; Zhang, Ye-Hui; Zhao, Fu-Rong; Tang, Bo-Hao; Zhang, Wei; Zhang, Xin-Fang; Fu, Shu-Meng; Hao, Guo-Xiang; Zheng, Yi; Shen, Jing-Shan; Xu, Ye-Chun; Jiang, Xiang-Rui; Zhang, Lei-Ke; Tang, Ren-Hong; Zhao, Wei
- Source
- In European Journal of Pharmaceutical Sciences 1 December 2023 191
- Subject
- Language
- ISSN
- 0928-0987